Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169815 · ClinicalTrials.gov registry record
Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 2,370
- Enrollment target
NCT04169815 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 2,370 participants.
The verdict
NCT04169815 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 2,370 participants
- Enrollment target
Study Summary
The purpose of the pivotal study is to collect blood specimens and clinical data from patients suspected of having Heart Failure (HF), which will be tested at a future date on Natriuretic Peptide assay(s) to validate diagnostic cutoffs and assess HF severity.
Interventions
- DIAGNOSTIC_TEST Access Immunodiagnostic Products
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,370 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2022-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04169815
The ClinicalTrials.gov registry entry for NCT04169815 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Access Immunodiagnostic Products is the first listed.
NCT04169815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04169815 about?
NCT04169815 is a clinical study titled "Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection". The purpose of the pivotal study is to collect blood specimens and clinical data from patients suspected of having Heart Failure (HF), which will be tested at a future date on Natriuretic Peptide assay(s) to validate diagnostic cutoffs and assess HF severity.
What is the current status of trial NCT04169815?
This trial is currently completed. The enrollment target is 2,370 participants. The study started on 2019-11-20. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04169815?
The interventions under investigation include: Access Immunodiagnostic Products (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04169815?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.